Mohali, Merjana S.
HRN: 24-31-90 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2024
CEFUROXIME 750MG (VIAL)
01/03/2024
01/09/2024
IVT
750mg
Q8hrs
UTI
Waiting Final Action